Penile injections are gaining popularity. Here’s everything you need to know about the procedure, including side effects and ...

Novartis, Amgen and Eli Lilly are betting that slashing levels of a particularly bad form of cholesterol could deliver the ...

Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting ...

Researchers are gaining a new appreciation for the genes on the X and Y chromosomes and how they shape sex differences in ...

Communication is the process of exchanging information, ideas, thoughts and emotions—whether through spoken words, written texts, facial expressions or digital media. It's the foundation of how we ...

Erectile disorder (ED) refers to a persistent difficulty achieving or maintaining an erection sufficient for satisfying ...

Preventing pregnancy is largely viewed as the responsibility of anyone who can become pregnant. It's a burden that can hold ...

Beth Skwarecki is Lifehacker’s Senior Health Editor, and holds certifications as a personal trainer and weightlifting coach. She has been writing about health for over 10 years. Let's talk about one ...

Scientists have discovered that combining two existing drugs can dramatically reduce liver fat linked to a common and often silent disease. The treatment not only improved liver health in animal ...

The FDA has approved the second GLP-1 pill for overweight and obesity. How does it compare to the Wegovy oral pill?

Studies show that ibogaine can be effective for short-term opioid addiction treatment, especially reducing drug cravings and some withdrawal symptoms.

President Trump has signed an executive order aimed at accelerating research and approval of psychedelics for treating mental health conditions, like depression, PTSD and addiction.